Apicomplexan parasites, including Plasmodium and Toxoplasma, are known to glide along surfaces without changing their shape. This form of movement enables them to easily enter and move between host cells. For example, upon entering the human body through a mosquito bite, Plasmodium glides through human skin before crossing into human blood vessels.

In a study published today in Communications Biology, scientists at EMBL Hamburg describe their work analyzing the molecular structure of essential light chains (ELCs), which are necessary for gliding, but their exact structure and role were unknown until now. The researchers obtained molecular structures of ELC bound to myosin A in Toxoplasma gondii and Plasmodium falciparum using X-ray crystallography and nuclear magnetic resonance (NMR).

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

The team found that ELCs work like 'molecular stilts'—upon binding myosin A, the ELCs become rigid, and start to act as its lever arm. This stiffening lets myosin make longer steps, which likely accelerates the parasite's gliding movements.

The researchers also investigated the role of calcium, a presumed gliding regulator, in the interaction between ELCs and myosin A. Surprisingly, they discovered that calcium does not influence the structure of ELCs. It does, however, increase the stability of the ELC-myosin A complex. This unexpected result shows that the glideosome architecture still hides many unknowns.

"This work has provided the first glimpse of how these organisms move around," says Matthew Bowler, an EMBL Grenoble researcher not involved in this study, who investigates Toxoplasma's strategies to control the immune system after invading cells. "It is fascinating to see new molecular details emerge on how these parasites work outside of the host cell. The beautiful structures show how the motor that drives this motion is put together, and could provide a basis to develop new medicines to treat these diseases," continues Bowler.